117 related articles for article (PubMed ID: 14575376)
21. Using technetium-99m tetrofosmin chest imaging to predict taxol-based chemotherapy response in non-small cell lung cancer but not related to lung resistance protein expression.
Shih CM; Shiau YC; Wang JJ; Ho ST; Kao A
Lung; 2003; 181(2):103-11. PubMed ID: 12953149
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
[TBL] [Abstract][Full Text] [Related]
23. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
24. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
25. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
26. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison with technetium-99m tetrofosmin single photon emission computed tomography and with magnetic resonance imaging.
Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
Anticancer Res; 2003; 23(1B):719-22. PubMed ID: 12680173
[TBL] [Abstract][Full Text] [Related]
27. [Can 67Ga citrate predict the efficacy of chemotherapy early in Hodgkin's lymphoma?].
Delgado M; Razola P; Abós MD; Martí JL; Murillo L; García F; Prats E; Banzo J
Rev Esp Med Nucl; 2001 Feb; 20(1):40-1. PubMed ID: 11181330
[No Abstract] [Full Text] [Related]
28. Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate.
Apostolopoulos DJ; Papandrianos NI; Symeonidis A; Spyridonidis T; Alexiou S; Zampakis P; Savvopoulos C; Vassilakos PJ; Matsouka P
Ann Nucl Med; 2010 Nov; 24(9):639-47. PubMed ID: 20799079
[TBL] [Abstract][Full Text] [Related]
29. Discordant response to chemotherapy between lymphadenopathy and bone lesions on gallium-67 scanning in Hodgkin's disease.
Bazarjani S; Di Primio G
Clin Nucl Med; 2005 Apr; 30(4):271-3. PubMed ID: 15764889
[TBL] [Abstract][Full Text] [Related]
30. The value of Tc-99m (V) dimercaptosuccinic acid in detecting intra-abdominal infection: compared with gallium scan.
Lin WY; Hung GU; Chao TH
Ann Nucl Med; 2007 Jul; 21(5):285-91. PubMed ID: 17634846
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
32. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
[TBL] [Abstract][Full Text] [Related]
33. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma.
Chen YK; Liu FY; Yen RF; Kao CH
Acad Radiol; 2003 Aug; 10(8):835-9. PubMed ID: 12945916
[TBL] [Abstract][Full Text] [Related]
34. 67Ga-citrate and 99Tcm-MDP for estimating the severity of vertebral osteomyelitis.
Gratz S; Dörner J; Oestmann JW; Opitz M; Behr T; Meller J; Grabbe E; Becker W
Nucl Med Commun; 2000 Jan; 21(1):111-20. PubMed ID: 10717911
[TBL] [Abstract][Full Text] [Related]
35. Myositis ossificans demonstrated by positive gallium-67 and technetium-99m-HMDP bone imaging but negative technetium-99m-MIBI imaging.
Shih WJ; Hackett MT; Stipp V; Gross K; Pulmano C
J Nucl Med Technol; 1999 Mar; 27(1):48-50. PubMed ID: 10322577
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
37. 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Li S; Kurtaran A; Li M; Traub-Weidinger T; Kienast O; Schima W; Angelberger P; Virgolini I; Raderer M; Dudczak R
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1087-95. PubMed ID: 12768334
[TBL] [Abstract][Full Text] [Related]
38. Scanning treated Hodgkin's disease with 67Ga citrate.
Henkin RE; Polcyn RE; Quinn JL
Radiology; 1974 Jan; 110(1):151-4. PubMed ID: 4808518
[No Abstract] [Full Text] [Related]
39. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
